Acquisition | ENDOCYTE INC | 26th December 2018

Due to the acquisition of   ENDOCYTE INC  by NOVARTIS AG , the following treatment will be applied to the following indices.

For:

Solactive US Small & Mid Cap Index
Solactive US Extended Broad Market Index
Solactive US Broad Market Index
Solactive US Small Cap Index

• ENDOCYTE INC will be removed from the Index.
• The weight of ENDOCYTE INC based on its last close price will be distributed pro rata to remaining Index constituents.
• Effective Date (open): 12/26/2018.